Abdominal Visceral Infarction in 3 Patients with COVID-19

Giulia Besutti, Riccardo Bonacini, Valentina Iotti, Giulia Marini, Nicoletta Riva, Giovanni Dolci, Mariarosa Maiorana, Lucia Spaggiari, Filippo Monelli, Guido Ligabue, Giovanni Guaraldi, Paolo Giorgi Rossi, Pierpaolo Pattacini, Marco Massari

Research output: Contribution to journalArticlepeer-review


A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with COVID-19 who developed abdominal viscera infarction, demonstrated by computed tomography.

Original languageEnglish
Pages (from-to)1926-1928
Number of pages3
JournalEmerging Infectious Diseases
Issue number8
Publication statusPublished - Aug 2020


  • Abdomen/blood supply
  • Aged
  • Anticoagulants/therapeutic use
  • Antiviral Agents/therapeutic use
  • Betacoronavirus/drug effects
  • COVID-19
  • Coronavirus Infections/complications
  • Drug Combinations
  • Heparin, Low-Molecular-Weight/therapeutic use
  • Humans
  • Hydroxychloroquine/therapeutic use
  • Infarction/complications
  • Italy
  • Lopinavir/therapeutic use
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral/complications
  • Ritonavir/therapeutic use
  • SARS-CoV-2
  • Thrombosis/complications
  • Tomography, X-Ray Computed
  • Viscera/blood supply


Dive into the research topics of 'Abdominal Visceral Infarction in 3 Patients with COVID-19'. Together they form a unique fingerprint.

Cite this